Animal Study: Semaglutide May Reduce Fetal Oxygen Supply

A small animal study in seven pregnant sheep suggests semaglutide (Ozempic) may reduce oxygen supply to developing fetuses, raising potential safety concerns for use during pregnancy. The finding is preliminary and based on animal models, with no direct human data yet. It matters because GLP-1 drugs are widely used and pregnancy exposure, though not recommended, can occur.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works